DRCR Retina Network Protocol AB compared aflibercept (Eylea, Regeneron) to PPV and PRP in patients with diabetic vitreous hemorrhage. DRCR Retina Network Vice Chair and Protocol AB chair Andrew Antoszyk, MD, joins\xa0NRR\xa0to review the study\u2019s findings, which were presented at this year\u2019s AAO Annual Meeting.\xa0\n\nThis editorially independent podcast is supported with advertising.